The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-((1-(2-(4,4-difluoropiperidin-1-yl)ethyl)-5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)amino)isonicotinic acid ID: ALA5290530
Chembl Id: CHEMBL5290530
Max Phase: Preclinical
Molecular Formula: C21H23F2N5O2
Molecular Weight: 415.44
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cnc2c(c1)c(Nc1cnccc1C(=O)O)cn2CCN1CCC(F)(F)CC1
Standard InChI: InChI=1S/C21H23F2N5O2/c1-14-10-16-18(26-17-12-24-5-2-15(17)20(29)30)13-28(19(16)25-11-14)9-8-27-6-3-21(22,23)4-7-27/h2,5,10-13,26H,3-4,6-9H2,1H3,(H,29,30)
Standard InChI Key: KDYQCOVJKZYFKX-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 415.44Molecular Weight (Monoisotopic): 415.1820AlogP: 3.91#Rotatable Bonds: 6Polar Surface Area: 83.28Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.00CX Basic pKa: 8.30CX LogP: 1.50CX LogD: 1.46Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.64Np Likeness Score: -0.88
References 1. Yang GJ, Wu J, Miao L, Zhu MH, Zhou QJ, Lu XJ, Lu JF, Leung CH, Ma DL, Chen J.. (2021) Pharmacological inhibition of KDM5A for cancer treatment., 226 [PMID:34555614 ] [10.1016/j.ejmech.2021.113855 ]